BSE: 524506 - Coral Laboratories Limited

Lønnsomhet i seks måneder: -19.84%
Utbytte: +0.23%

Kampanjeplan Coral Laboratories Limited


Om selskapet Coral Laboratories Limited

Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethopia, and internationally.

flere detaljer
The company offers antibiotics/antibacterial products, including antifungal, antiemetic, analgesics/antipyretic/antiinflammatory, antispasmodic, anticold, antiallergic, antiasthmatic, antidiabetic, antiemetics, anthelmentic, thyroid, and antiprotozoal/antiamebic products; antimalarial drugs, antipsychotic drugs, gastro-intestinal drugs, kits, muscle relaxants, cough suppressant/expectorant products, cardiovascular medicines, oral antiseptic preparations, mouthwashes, calcium preparations, and appetizers; and nutritional, protein, and iron supplements, as well as other products. It also provides cephalosporin, beta lactam, and lyophilized injectable products; eye/ear/nose drops; nasal sprays and metered dose inhales; and large volume parenteral products. In addition, the company offers various nutraceutical products, such as dietary supplements, herbal/phytochemicals, multivitamins, and nutrients, as well as OTC products. It provides its products in various dosage forms, including tablets, capsules, low RH facilities, liquid orals, liquids and powders, dry syrups, drops, ointment and creams, gels and lotions, granules powders, injectables, nasal sprays, and suppositories. Coral Laboratories Limited was incorporated in 1994 and is headquartered in Mumbai, India.

Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.23
Дивиденд ао 2
Сайт http://corallab.com
Цена ао 757.6
Prisendring per dag: -2.54% (747.35)
Prisendring per uke: -1.55% (739.8)
Prisendring per måned: -9.81% (807.6)
Prisendring over 3 måneder: -4.44% (762.2)
Prisendring over seks måneder: -19.84% (908.6)
Prisendring per år: +93.76% (375.9)
Prisendring over 3 år: +114.98% (338.8)
Prisendring over 5 år: +432.03% (136.9)
Prisendring over 10 år: 0% (728.35)
Prisendring siden begynnelsen av året: -7.8% (789.95)

Undervurdering

Navn Betydning Karakter
P/S 1.72 8
P/BV 0.7979 9
P/E 8.97 9
EV/EBITDA 0 0
Total: 8

Effektivitet

Navn Betydning Karakter
ROA, % 8.31 3
ROE, % 9.5 3
Total: 2

Utbytte

Navn Betydning Karakter
Div yield, % 0.23 0.58
DSI 0.9286 9.29
Total: 1.91

Plikt

Navn Betydning Karakter
Debt/EBITDA 0 10
Total: 10

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 16.32 3
Lønnsomhet Ebitda, % 0 5
Lønnsomhet EPS, % 121.44 10
Total: 7.6

Veileder Stillingstittel Betaling Fødselsår
Mr. Girish Madanlal Dhameja Whole-Time Director 1981 (44 år)
Ms. Sushma Shashi Kadkade CFO & Non-Exec. Director 1976 (49 år)
Ms. Ruchi Anjaria Company Sec. & Compliance Officer
Mr. Kapil K. Shah Exec. Officer

Adresse: India, Mumbai, #3B Patanwala Industrial Estate - åpne i Google maps, åpne Yandex-kart
Nettsted: http://corallab.com